Corporate Social Responsibility | Business Wire | PR NewsWire | Marketwire | Realwire | ACN/JCN newswire | 247pressrelease | PRWeb

AVI BioPharma Announces Third Quarter 2009 Financial Results Conference Call

Posted : Mon, 02 Nov 2009 13:01:41 GMT
Author : AVI BioPharma, Inc.
Category : Press Release
News Alerts by Email ( click here )
News | Home
BOTHELL, WA -- 11/02/09 -- AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based drugs, will hold a conference call to report third quarter 2009 financial results on Monday, Nov. 9, 2009, at 9:30 a.m. Eastern time (6:30 a.m. Pacific time).

Individuals interested in listening to the live conference call may do so by dialing 877-591-4956 toll free within the United States and Canada, or 719-325-4775 for international callers.

A replay of the call will be available by dialing 888-203-1112 toll free within the U.S. and Canada or 719-457-0820 for international callers. The passcode for the replay is 4369547. In addition, a recording of the call will be available within approximately 24 hours at www.avibio.com.

About AVI BioPharma

AVI BioPharma is focused on the discovery and development of RNA-based drugs utilizing proprietary derivatives of its antisense chemistry (morpholino-modified phosphorodiamidate oligomers or PMOs) that can be applied to a wide range of diseases and genetic disorders through several distinct mechanisms of action. Unlike other RNA therapeutic approaches, AVI's antisense technology has been used to directly target both messenger RNA (mRNA) and its precursor (pre-mRNA), allowing for both up- and down-regulation of targeted genes and proteins. AVI's RNA-based drug programs are being evaluated for the treatment of Duchenne muscular dystrophy as well as for the treatment of cardiovascular restenosis through our partner Global Therapeutics, a Cook Group Company. AVI's antiviral programs have demonstrated promising outcomes in Ebola Zaire and Marburg Musoke virus infections and may prove applicable to other viral targets such as influenza, HCV or Dengue viruses. For more information, visit www.avibio.com.

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: The statements that are not historical facts contained in this release are forward-looking statements that involve risks and uncertainties, including, but not limited to, the results of research and development efforts, the results of preclinical and clinical testing, the effect of regulation by the FDA and other agencies, the impact of competitive products, product development, commercialization and technological difficulties, and other risks detailed in the company's Securities and Exchange Commission filings.

AVI Press and Investor Contact:
Julie Rathbun
Investor Relations
(541) 224-2575
Investorrelations@avibio.com


Copyright © 2008 Market Wire. All rights reserved.
Share/Save/Bookmark

Article : AVI BioPharma Announces Third Quarter 2009 Financial Results Conference Call
Print this article
Share this article

Stay Updated

News gadget on your Google homepage
Subscribe to a news feed in Google Reader



Related News

Colombian National Pleads Guilty to Role in Defrauding the Export-Import Bank of the United States of More Than $1 Million
WASHINGTON, Nov. 23 /PRNewswire-USNewswire/ -- Febe Durango-Rueda, 52, a Colombian national, pleaded guilty on Nov. 20, 2009, to participating in a scheme to defraud the Export-Import Bank of the United States (Ex-Im Bank) of more than $1 million, announced Assistant Attorney General of...

Alpharetta Man Pleads Guilty to Impersonation of National Security Agent
Aprile Held Himself out to Alpharetta & Marietta Police Departments as Anti-Terrorism Task Force Leader ATLANTA, Nov. 23 /PRNewswire-USNewswire/ -- Louis Joseph Aprile, 49, of Alpharetta, Ga., pleaded guilty today in federal district court to the offense of ...

Healthy Eating: Your Healthy Recipes Wanted by Healthy Life Network
CHICAGO, IL -- 11/23/09 -- Healthy Life Network, the new online source for all that is healthy, is now accepting healthy recipe submissions from its readers. Those

Dean Foods Company Chairman and CEO Completes Previously Disclosed Forward Sale Agreement
DALLAS, Nov. 23 -- Dean Foods Company (NYSE: DF) today announced that the previously disclosed variable prepaid forward sale contract entered into between Gregg Engles, Chairman and CEO and an unaffiliated third party on November 21, 2008 has partially settled...

Pinnacle Announces Third Quarter Earnings
SHERIDAN, Wyo., Nov. 23 -- Pinnacle Gas Resources, Inc. (Nasdaq: PINN) today reported the Company's financial results for the third quarter and nine months ended September 30, 2009 which included the following information: Resul...

Closing Arguments Begin in the Trial of Khmer Rouge Official Kaing Guek Eav
CHICAGO, Nov. 23 /PRNewswire/ -- Northwestern University Law Professor David Scheffer is in Phnom Penh, Cambodia this week to analyze and provide commentary on closing arguments in the trial of Kaing Guek Eav (alias "Duch"). The trial, which began in March of t...

Health Net Reschedules Its Investor Day to February 11, 2010
LOS ANGELES - Health Net, Inc. (NYSE:HNT) today announced that it is rescheduling its annual Investor Day from December 11, 2009, to February 11, 2010. The company expects to issue its 2010 earnings guidance on December 11, 2009. “In light of the recent decision by the

Have your Say
Name
Email
Subject
Your Comment

Enter Verification code
 
  

 
Follow The Earth Times
Subscribe to RSS Follow Earth Times on TwitterNews by email
Share/Save/Bookmark
 
 



 
Subscribe to free Earthtimes
News Alerts by Email Click here
For RSS Feeds Click here
or Create your own RSS

Add to Google Toolbar
Breaking News
Press Releases

 


The Earth Times
News Category

© 2009 www.earthtimes.org, The Earth Times, All Rights Reserved | Privacy Policy
Earth Times accept no responsibility or liability either directly or indirectly for views or opinions expressed in articles or comments.